ArticleBlood advances2022
CCR8 is a new therapeutic target in cutaneous T-cell lymphomas.
Jérôme Giustiniani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleBlood advances2022
Jérôme Giustiniani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.